Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.

Source:http://linkedlifedata.com/resource/pubmed/id/10784629

Download in:

View as

General Info

PMID
10784629